This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| BBMRI | |
|---|---|
| Name | BBMRI |
| Type | Research infrastructure |
| Founded | 2008 |
| Focus | Biobanking, biomaterials, translational research |
| Headquarters | Europe |
BBMRI
BBMRI is a European research infrastructure for biobanking and biomolecular resources that connects major biobanks, research centers, and clinical institutions across Europe. It facilitates access to human biological materials and associated data to support biomedical research, personalized medicine, and public health initiatives. BBMRI interfaces with national research agencies, supranational programs, and translational networks to harmonize sample access, quality standards, and data interoperability.
BBMRI operates as a distributed research infrastructure linking national nodes such as Max Delbrück Center for Molecular Medicine, Karolinska Institutet, Institut Pasteur, Helmholtz Association, CNIO Spanish National Cancer Research Centre, University of Oxford, University of Cambridge, University of Helsinki, University of Milan, and University of Zurich. It provides services overlapping with infrastructures like ELIXIR, European Molecular Biology Laboratory, European Bioinformatics Institute, EATRIS, Euro-BioImaging, and ISBER. BBMRI’s remit includes harmonizing sample collection procedures influenced by guidelines from World Health Organization, European Commission, Council of Europe, OECD, and collaborations with projects funded by Horizon 2020 and Horizon Europe.
The initiative emerged from coordinated European efforts following frameworks promoted by European Strategy Forum on Research Infrastructures and discussions at meetings involving representatives from Wellcome Trust, European Research Council, European Medicines Agency, European Centre for Disease Prevention and Control, and national ministries such as Ministry of Health (France), Bundesministerium für Bildung und Forschung, and Ministry of Education and Culture (Finland). Early phases involved pilot projects coordinated alongside consortia including BBMRI-ERIC Preparatory Phase and partnerships with networks like European Genome-phenome Archive and cohorts such as UK Biobank, Estonian Biobank, FinnGen, HUNT Study, Framingham Heart Study, and EPIC (European Prospective Investigation into Cancer and Nutrition). Subsequent legal establishment aligned with instruments from the European Research Area and recognition under the European Strategy Forum on Research Infrastructures roadmap.
Governance combines national nodes and a central legal entity with advisory boards and committees including scientific boards that draw expertise from institutions such as National Institutes of Health, Institut National de la Santé et de la Recherche Médicale, Pasteur Institute, Karolinska University Hospital, and universities like Imperial College London and KU Leuven. Governance mechanisms incorporate stakeholder representation from patient organizations such as European Patients' Forum and professional associations including European Federation of Pharmaceutical Industries and Associations and International Society for Biological and Environmental Repositories. Decision-making follows frameworks similar to those used by European Research Council and boards modeled after structures from European Molecular Biology Laboratory and European Space Agency.
BBMRI provides cataloguing and sample access services that integrate with standards promoted by International Organization for Standardization, Clinical and Laboratory Standards Institute, Good Clinical Practice (GCP), and guidance from Declaration of Helsinki. Technical services map to platforms and tools such as Biobanking and BioMolecular resources Research Infrastructure Directory, interoperability resources used by European Nucleotide Archive, ArrayExpress, Protein Data Bank, and data models informed by OMOP Common Data Model, HL7, and FHIR. BBMRI supports quality management, cold-chain logistics, sample processing workflows used in centers like Charité – Universitätsmedizin Berlin, Mayo Clinic, Cleveland Clinic, and cryostorage facilities following practices from European Centre for Disease Prevention and Control guidelines.
BBMRI facilitates translational research collaborations with consortia including European Cancer Organisation, Innovative Medicines Initiative, GA4GH (Global Alliance for Genomics and Health), Human Cell Atlas, EPIC Consortium, and disease-focused networks like Alzheimer’s Disease Neuroimaging Initiative, International Cancer Genome Consortium, 1000 Genomes Project, and cohort initiatives such as Rotterdam Study. It supports multi-center studies bridging partners like European Society of Human Genetics, European Respiratory Society, European Society of Cardiology, European Association for the Study of Diabetes, and pharmaceutical partners including GlaxoSmithKline, Roche, Novartis, and Pfizer.
Funding streams derive from national research councils such as UK Research and Innovation, Agence Nationale de la Recherche, Deutsche Forschungsgemeinschaft, and EU programs including Horizon 2020 and Horizon Europe. Ethical and legal frameworks align with instruments and rulings from General Data Protection Regulation, European Court of Justice, Council of Europe Convention on Human Rights and Biomedicine (Oviedo Convention), and guidance from European Data Protection Board and national authorities like CNIL. BBMRI’s policies reference ethical standards from World Medical Association and engagement models used by European Patients' Academy on Therapeutic Innovation.
BBMRI has enhanced access to biomaterials and metadata supporting publications in journals such as Nature, Science, The Lancet, Nature Genetics, Nature Medicine, and Cell. It enabled studies that integrated datasets from UK Biobank, FinnGen, Estonian Biobank, Framingham Heart Study, and EPIC leading to discoveries cited by institutions like European Medicines Agency and World Health Organization. Recognition includes collaborations with awardees of Lasker Award, Breakthrough Prize, European Inventor Award, and contributions to initiatives acknowledged by European Research Council grantees.
Category:Research infrastructures in Europe